English
- استرجاع مجاني وسهل
- أفضل العروض
Levodopa and Carbidopa Controlled Release Matrix Tablets
الآن:
222.00 د.إ.شامل ضريبة القيمة المضافة
توصيل مجاني
احصل عليه خلال 28 فبراير - 1 مارس
احصل على 5% رصيد مسترجع باستخدام بطاقة بنك المشرق نون الائتمانية. اشترك الآن. قدّم الحين
1
توصيل مجاني لنقطة نون ومراكز الاستلام
معرفة المزيد
إرجاع سهل لكل المنتجات في هذا العرض.
المواصفات
| الناشر | LAP Lambert Academic Publishing |
| رقم الكتاب المعياري الدولي 13 | 9783838348117 |
| رقم الكتاب المعياري الدولي 10 | 3838348117 |
| الكاتب | Jagan Mohan Somagoni |
| اللغة | English |
| وصف الكتاب | In recent years, in association with progress and innovation in the field of pharmaceutical technology, there has been an increasing effort to develop prolonged release dosage forms for many drugs. Correspondingly, a growing number of new prolonged release dosage forms have been submitted for regulatory approval. Prolonged release dosage forms have many advantages in safety and efficacy over immediate release drug products in that the frequency of dosing can be reduced, drug efficacy can be prolonged and the incidence and/or intensity of adverse effects can be decreased. However, some prolonged release dosage forms have less clear rationale or are developed for active ingredients which are not appropriate for prolonged release dosage forms. In other cases, prolonged release dosage forms are designed without full consideration of the basic properties of the drugs. Moreover, standards for dissolution tests, which are important for evaluating prolonged release dosage forms, have not appropriately been established. As a result, it is often difficult to evaluate whether a prolonged release dosage form is acceptable or not. |
| تاريخ النشر | 7 May 2010 |
| عدد الصفحات | 72 pages |
Levodopa and Carbidopa Controlled Release Matrix Tablets
تمت الإضافة لعربة التسوق
مجموع السلة 222.00 د.إ.
